Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)

NCT07500285 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Metastatic Lung Carcinoma

Interventions

DRUG: Yttrium-90-Labeled Fibroblast Activation Protein Inhibitor (Y-90 FAPI)

Sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Collaborators

[object Object]